Industry
Global Hemostasis Analyzers Market Driven by Increasing Awareness of Blood Disorder Conditions
The global hemostasis analyzers market is expected to reach USD 5.97 billion in 2026, driven by the increasing awareness of blood disorder conditions such as Hemophilia and Von Willebrand disease (vWD) which are genetic disorders and not well known to people. This results in late diagnosis of blood disorders and affects patient outcomes. The increasing awareness is expected to improve the diagnosis rate of blood disorders, thereby driving the demand for hemostasis analyzers. More...09 Feb 2023
Chembio and Biosynex to Merge, Forging US-French Point-of-Care Testing Powerhouse
Biosynex SA, a French company specializing in the design and distribution of rapid tests, and Chembio Diagnostics, Inc., a leading point-of-care diagnostics company in the U.S. that is focused on infectious diseases, have entered into a definitive merger agreement under which Biosynex, through a subsidiary, will acquire Chembio in an all-cash transaction valued at USD 17.2 million. More...02 Feb 2023
CerTest to Run ‘More than Diagnostics’ Campaign Throughout 2023
CerTest Biotec has announced that the company will run its campaign ‘More than Diagnostics’ throughout 2023 in acknowledgement of the transformation that it has gone through, accelerated by the COVID-19 pandemic. CerTest’s ‘More than Diagnostics’ campaign expresses the company’s ambition to continue growing and advancing towards an exciting future, with people’s health remaining its key focus. More...01 Feb 2023
New Collaboration to Apply Power of AI to Digital Pathology Images
Clinical artificial intelligence (AI) applications have the potential to help pathologists diagnose cancer more confidently and efficiently, ultimately improving patient care. Now, a new collaboration aims to lead the digital transformation of pathology and cancer diagnosis. More...30 Jan 2023
Point-of-Care Glucose Testing Market to Reach Almost USD 6 Billion by 2032
The global point-of-care (POC) glucose testing market is projected to register a CAGR of 4.3% during the forecast period from 2022 to 2032 to reach USD 5.8 billion by 2032, driven by a rise in the geriatric population, speed & precision of POC screening, increased adoption of electronic medical information, and the higher risk of COVID-19-related mortality associated with diabetes. More...25 Jan 2023
Carolina Liquid Chemistries and Diazyme Enter Into Partnership
Carolina Liquid Chemistries, Corp. (CLC, Greensboro, NC, USA) and Diazyme Laboratories, Inc. (San Diego, CA, USA) have entered into a partnership to expand the test menu on the Diazyme DZ-Lite c270 benchtop clinical chemistry analyzer, allowing it to run both special and routine chemistries. More...24 Jan 2023
Siemens Launches Centre of Excellence for Immunoassay Instrument R&D in Ireland
Siemens Healthineers has launched a Center of Excellence for Immunoassay Instrument Research and Development (R&D) in Swords, Ireland. The new center will focus on unlocking breakthrough innovations in laboratory instruments used to detect infectious diseases, cancer and blood disorders. More...23 Jan 2023
Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
In Other News
Medlab Middle East Sees 100% Increase in Exhibitor Numbers
Thermo Fisher Completes Acquisition of UK’s Binding Site
Tianlong’s PCR Lab Solution Safeguards 2022 G20 Indonesia Summit
Tianlong Contributes to China’s Power to Prevent and Control Global Epidemics
Global Urinalysis Market Driven by Increasing Burden of UTIs, Diabetes, and Kidney & Liver Diseases
Fujifilm Enters Digital Pathology Space with Acquisition of Inspirata
Global POC Diagnostics Market Driven by Growing Demand for Portable and Handheld Near-Patient Devices
Global Microplate Readers Market Driven by Rising Incidence of Infectious Diseases
AI-Based Digital Pathology Solutions Market Driven by Benefits of More Precise and Reproducible Diagnoses
Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling
Roche Introduces Digital Health Solutions Under Navify Brand
Werfen to Acquire Transfusion and Transplant Diagnostics Innovator for Around USD 2 Billion
Mast Group Enters into Multi-Country Distribution Agreement for Nanomix's eLab System
AI-Enabled Diagnostic Testing Could Become More Accurate and Reliable than Current Tests
Global Infectious Respiratory Disease Diagnostics Market Driven by New Multiplex PCR Tests and POC Products
UK's Binding Site to Be Acquired by Thermo Fisher for USD 2.6 Billion
Nova Primary Blood Glucose Reference Analyzer Receives US FDA Clearance
AACC Middle East to Showcase Latest in Laboratory Medicine and Diagnostic Innovations
Global Lateral Flow Assay Market Driven by Rising Incidence of Infectious Diseases
Global Multiplex Detection Immunoassays Market Driven by Demand for Clinical Diagnostic Applications
Global Sepsis Diagnostics Market Driven by Increasing Prevalence of Bacterial Infections
AACC Competition Demonstrates How Labs Can Use Data Analytics to Solve Real Problems
MEDICA 2022 to Focus on How Health IT Can Contribute to More Sustainability in Health Care
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.